Redenlab is excited to announce that Prof. Adam Vogel will be speaking at the upcoming International Congress for Ataxia Research in London on November 14, 2024. He’ll be joining leading experts in a workshop centered on promising fluid and digital biomarkers for ataxia research. These innovative biomarkers hold the potential to revolutionise clinical trials, providing valuable insights into treatment efficacy and target engagement.

The workshop will be co-chaired by Dr. Anoopum Gupta (Massachusetts General Hospital, Harvard Medical School) and Dr. Giulia Coarelli (Sorbonne University) and hosted by Ataxia UK, the National Ataxia Foundation (NAF), the Friedreich’s Ataxia Research Alliance (FARA), and the Ataxia Global Initiative (AGI).

ICAR 2024 will feature a dynamic program including plenary and parallel sessions, workshops, and poster presentations. Building on the success of ICAR 2022, this year’s program will include a panel discussion with individuals affected by ataxia and an engaging debate session.

To learn more about the conference, visit: International Congress for Ataxia Research

Stay connected with Redenlab as we continue to advance speech research in rare diseases, transforming lives through cutting-edge science.